September 2002
From Moffitt Cancer Center and Research Institute
Moffitt Cancer Center to sponsor the Second Biennial Molecular Targets for Cancer Therapy Symposium The H. Lee Moffitt Cancer Center & Research Institute will sponsor the Second Biennial Molecular Targets for Cancer Therapy symposium. This NCI-supported meeting is designed to foster the exchange of the most recent findings and concepts in cancer biology and to discuss how these ideas can be applied toward drug targets. Topics to be covered include gene regulation, signal transduction, immunology, apoptosis, and molecular therapeutics. The goal is to provide an in-depth view of these fast-moving fields so that information and advances in specific areas can be rapidly disseminated and applied to new problems. Special emphasis will be placed on bridging basic science and clinical research and creating new collaborations between disciplines.The meeting will be held October 11-15, 2002 at the Don CeSar Beach Resort & Spa on St. Petersburg Beach, located 30 minutes from the H. Lee Moffitt Cancer Center at the University of South Florida in Tampa. The conference program will consist of a keynote address and 6 plenary sessions. Conference Speakers: Welcome Address:
William S. Dalton, Ph.D., M.D.
Center Director
H. Lee Moffitt Cancer Center & Research Institute Keynote Address:
James E. Darnell, Jr., M.D.
Vincent Astor Professor and Head
Laboratory of Molecular Cell Biology
The Rockefeller University Session I: Gene Regulation
Chair: C. David Allis, Ph.D
University of Virginia Session II: Signal Transduction
Chair: Sara Courtneidge, Ph.D
Van Andel Research Institute Session III: Immunology
Chair: Rainer Storb, M.D.
Fred Hutchinson Cancer Research Center Session IV: Molecular Markers for Cancer Detection
Chair: Adi F. Gazdar, M.D.
University of Texas Southwestern Medical Center
Dallas, Texas Session V: Apoptosis
Chair: Vishva Dixit, Ph.D
Genetech, Inc. Session VI: Molecular Therapeutics
Chair: Stanton L. Gerson, M.D.
Case Western Reserve University and University Hospitals of Cleveland, Ohio To view the Molecular Targets 2002 brochure in its entirety, go to www.moffitt.usf.edu/promotions/molecular/index.htm Course Objectives
As a result of participating in this educational program, participants will be able to:
-- Discuss recent progress on the role of chromatin modifying enzymes in cellular processes and evaluate inhibitors of these enzymes for cancer therapy.
-- Discuss the roles of signal transduction pathways in oncogenesis and evaluate signaling proteins as novel molecular targets for cancer therapy.
-- Discuss recent progress and future directions in allogeneic bone marrow transplantation for cancer.
-- Discuss cellular regulatory mechanisms as potential targets for potential cancer chemoprevention strategies and the identification of cancer-susceptible populations.
-- Discuss the current understanding of potential therapeutic targets for apoptosis triggered by anticancer drugs.
-- Discuss the current state of molecular therapeutics in cancer and identify new trends for the future of this field. Accreditation For Physicians:
This activity has been planned and implemented in accordance with the Essentials Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute. The University of South Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of South Florida College of Medicine designates this educational activity for a maximum of 20.5 hours in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. | 